P003 ROSE trial: A prospective non-interventional study to assess the quality of life (QoL) of premenopausal patients with early breast cancer receiving triptorelin as ovarian function suppression. (April 2023) - Mauri, G.; Perrot, V.; Mazzanti, P.; De Laurentiis, M.; Pagani, O.; Munzone, E.